Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens

BACKGROUND: Passive immunotherapy using polyclonal antibodies (immunoglobulins) has been used for over a century in the treatment and post-exposure prophylaxis of various infections and toxins. Heterologous polyclonal antibodies are obtained from animals hyperimmunised with a pathogen or toxin. AIMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixit, Rashmi, Herz, Jenny, Dalton, Richard, Booy, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131169/
https://www.ncbi.nlm.nih.gov/pubmed/26802604
http://dx.doi.org/10.1016/j.vaccine.2016.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131169/
https://www.ncbi.nlm.nih.gov/pubmed/26802604
http://dx.doi.org/10.1016/j.vaccine.2016.01.016

Ejemplares similares